Literature DB >> 10758050

Myofilament calcium regulation in human myocardium.

R J Hajjar1, R H Schwinger, U Schmidt, C S Kim, D Lebeche, A A Doye, J K Gwathmey.   

Abstract

BACKGROUND: We investigated whether decreased myofilament calcium contractile activation may, in part, contribute to heart failure. METHODS AND
RESULTS: Calcium concentration required for 50% activation and Hill coefficient for fibers from nonfailing and failing human hearts at pH 7.1 were not different. Maximum calcium-activated force (F(max)) was also not different. However, at pH 6.8 and 6.9, differences were seen in myofilament calcium activation between nonfailing and failing hearts. At lower pH, failing myocardium was shifted left on the calcium axis compared with nonfailing myocardium, which suggested an increase in myofilament calcium responsiveness. Increased inorganic phosphate concentration decreased maximal force development by 56% in nonfailing and 36% in failing myocardium and shifted the calcium-force relationship by 2.01+/-0.22 versus 0.86+/-0.13 micromol/L, respectively (P<0.05). Addition of cAMP resulted in a 0. 56 micromol/L shift toward higher intracellular calcium concentrations in nonfailing myocardium and a 1.04 micromol/L shift in failing myocardium. Protein kinase A in the presence of cAMP resulted in a further rightward shift in nonfailing human myocardium but did not further shift the calcium-force relationship in fibers from failing hearts. cGMP also resulted in a greater decrease in myofilament calcium sensitivity in fibers from failing hearts.
CONCLUSIONS: We propose that changes at the level of the thin myofilaments result in differential responses to changes in the intracellular milieu in nonfailing versus failing myocardium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10758050      PMCID: PMC1249501          DOI: 10.1161/01.cir.101.14.1679

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  38 in total

1.  Myosin and why hearts fail.

Authors:  R J Solaro
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

2.  Altered myocardial force-frequency relation in human heart failure.

Authors:  L A Mulieri; G Hasenfuss; B Leavitt; P D Allen; N R Alpert
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

3.  Light chain 2 profile and activity of human ventricular myosin during dilated cardiomyopathy. Identification of a causal agent for impaired myocardial function.

Authors:  S S Margossian; H D White; J B Caulfield; P Norton; S Taylor; H S Slayter
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

4.  Troponin I gene expression during human cardiac development and in end-stage heart failure.

Authors:  S Sasse; N J Brand; P Kyprianou; G K Dhoot; R Wade; M Arai; M Periasamy; M H Yacoub; P J Barton
Journal:  Circ Res       Date:  1993-05       Impact factor: 17.367

5.  Phosphorylation of cardiac troponin inhibitory subunit (troponin I) and tropomyosin-binding subunit (troponin T) by cardiac phospholipid-sensitive Ca2+-dependent protein kinase.

Authors:  N Katoh; B C Wise; J F Kuo
Journal:  Biochem J       Date:  1983-01-01       Impact factor: 3.857

6.  Troponin I isoform expression in human heart.

Authors:  N M Hunkeler; J Kullman; A M Murphy
Journal:  Circ Res       Date:  1991-11       Impact factor: 17.367

7.  Contractile deactivation and uncoupling of crossbridges. Effects of 2,3-butanedione monoxime on mammalian myocardium.

Authors:  J K Gwathmey; R J Hajjar; R J Solaro
Journal:  Circ Res       Date:  1991-11       Impact factor: 17.367

8.  Cross-bridge dynamics in human ventricular myocardium. Regulation of contractility in the failing heart.

Authors:  R J Hajjar; J K Gwathmey
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

9.  Contractile properties and Ca2+ release activity of the sarcoplasmic reticulum in dilated cardiomyopathy.

Authors:  A D'Agnolo; G B Luciani; A Mazzucco; V Gallucci; G Salviati
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

10.  Effect of cross-bridge kinetics on apparent Ca2+ sensitivity.

Authors:  P W Brandt; R N Cox; M Kawai; T Robinson
Journal:  J Gen Physiol       Date:  1982-06       Impact factor: 4.086

View more
  10 in total

1.  S100A1: a regulator of myocardial contractility.

Authors:  P Most; J Bernotat; P Ehlermann; S T Pleger; M Reppel; M Börries; F Niroomand; B Pieske; P M Janssen; T Eschenhagen; P Karczewski; G L Smith; W J Koch; H A Katus; A Remppis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

Review 2.  Targeting calcium cycling proteins in heart failure through gene transfer.

Authors:  Federica del Monte; Roger J Hajjar
Journal:  J Physiol       Date:  2003-01-01       Impact factor: 5.182

3.  Insight into the role of DL-alpha-lipoic acid against cyclophosphamide induced alterations in calcium sensitivity of cardiac myofilaments.

Authors:  Y Mythili; P T Sudharsan; P Varalakshmi
Journal:  Mol Cell Biochem       Date:  2006-04-20       Impact factor: 3.396

4.  Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins.

Authors:  Susumu Sakata; Djamel Lebeche; Naoya Sakata; Yuri Sakata; Elie R Chemaly; Li Fan Liang; Tsuyoshi Tsuji; Yoshiaki Takewa; Federica del Monte; Richard Peluso; Krisztina Zsebo; Dongtak Jeong; Woo Jin Park; Yoshiaki Kawase; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2007-01-10       Impact factor: 5.000

5.  Functional consequences of caspase activation in cardiac myocytes.

Authors:  Catherine Communal; Marius Sumandea; Pieter de Tombe; Jagat Narula; R John Solaro; Roger J Hajjar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

6.  Reduced length-dependent cross-bridge recruitment in skinned fiber preparations of human failing myocardium.

Authors:  Klara Brixius; Persephone Savidou-Zaroti; Wilhelm Bloch; Robert H G Schwinger
Journal:  Eur J Appl Physiol       Date:  2003-02-28       Impact factor: 3.078

7.  Reduced troponin I phosphorylation and increased Ca(2+)-dependent ATP-consumption in triton X-skinned fiber preparations from Galphaq overexpressor mice.

Authors:  C Pott; L Willkomm; S Grafweg; B Bölck; G W Dorn; R H G Schwinger; K Brixius
Journal:  Mol Cell Biochem       Date:  2008-05-13       Impact factor: 3.396

8.  Molecular and functional characterization of a novel cardiac-specific human tropomyosin isoform.

Authors:  Sudarsan Rajan; Ganapathy Jagatheesan; Chehade N Karam; Marco L Alves; Ilona Bodi; Arnold Schwartz; Christian F Bulcao; Karen M D'Souza; Shahab A Akhter; Greg P Boivin; Dipak K Dube; Natalia Petrashevskaya; Andrew B Herr; Roger Hullin; Stephen B Liggett; Beata M Wolska; R John Solaro; David F Wieczorek
Journal:  Circulation       Date:  2010-01-11       Impact factor: 29.690

9.  Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats.

Authors:  Lin Zhang; Marie-Louise Ward; Anthony R J Phillips; Shaoping Zhang; John Kennedy; Bernard Barry; Mark B Cannell; Garth J S Cooper
Journal:  Cardiovasc Diabetol       Date:  2013-08-28       Impact factor: 9.951

Review 10.  Calcium and Heart Failure: How Did We Get Here and Where Are We Going?

Authors:  Natthaphat Siri-Angkul; Behzad Dadfar; Riya Jaleel; Jazna Naushad; Jaseela Parambathazhath; Angelia A Doye; Lai-Hua Xie; Judith K Gwathmey
Journal:  Int J Mol Sci       Date:  2021-07-09       Impact factor: 6.208

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.